Watts Gwilliam & Co., LLC Anavex Life Sciences Corp. Call Options Transaction History
Watts Gwilliam & Co., LLC
- $498 Million
- Q1 2025
Call Options
1 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$57.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$44.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$17.7 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$9.03 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $704M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...